Cerebrovascular accidents after percutaneous coronary interventions from 2002 to 2014: Incidence, outcomes, and

Romain Didier1, Michael A Gaglia1, Edward Koifman1

  • 1MedStar Washington Hospital Center, Washington, DC.

American Heart Journal
|February 10, 2016
PubMed

Insights

Neurologic events like stroke (CVA) and TIA after percutaneous coronary intervention (PCI) are rare but serious. Despite rising patient risk factors, the incidence of these events remained stable over 12 years.

Area of Science:

  • Cardiology
  • Neurology
  • Interventional Cardiology

Background:

  • Cerebrovascular accident (CVA) and transient ischemic attack (TIA) are rare but severe complications of percutaneous coronary intervention (PCI).
  • These neurologic events are linked to significantly increased morbidity and mortality.
  • Understanding trends and risk factors is crucial given evolving PCI techniques and patient demographics.

Purpose of the Study:

  • To evaluate trends in CVA and TIA incidence following PCI.
  • To identify patient and procedural variables associated with post-PCI neurologic events.
  • To assess the impact of these events on patient outcomes.

Main Methods:

  • A prospective study of 25,626 consecutive patients undergoing PCI between 2002 and 2015.
  • Data collected included baseline characteristics, procedural details, in-hospital outcomes, and 1-year mortality.
  • Patients experiencing CVA or TIA were compared to those without neurologic events.

Main Results:

  • The overall incidence of post-PCI neurologic events was 0.43% (86 CVAs, 24 TIAs).
  • Patients with neurologic events had higher rates of prior CVA, chronic kidney disease, diabetes, acute myocardial infarction, and cardiogenic shock.
  • Intraaortic balloon pump use, prior CVA, and African American race were significantly associated with increased risk of neurologic events.

Conclusions:

  • Post-PCI neurologic events are associated with substantially worse in-hospital and 1-year mortality.
  • Despite increasing patient risk factors, the incidence of CVA and TIA post-PCI remained stable over the study period.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
398
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
695
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
839
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.6K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
439
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
545